文献速递血管炎

颞动脉炎揭示抗中性粒细胞胞浆抗体相关性血管炎:病例对照研究

Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.
PubMed 文献 · Arthritis Rheumatol · 2020-12-21

该回顾性病例对照研究比较了以颞动脉炎表现揭示的抗中性粒细胞胞浆抗体相关性血管炎(TA-AAV)患者与经典巨细胞动脉炎(GCA)对照的临床、生物学及组织学表现和结局。研究发现TA-AAV患者更年轻、男性更多、非典型表现频率高且C反应蛋白水平更高,延迟诊断者治疗失败风险显著增加(HR 3.85,95%CI 1.97-7.51;P < 0.0001)。

要点

  • GCA非典型表现、糖皮质激素抵抗或早期复发时应考虑TA-AAV。
  • 颞动脉活检见小分支血管炎和/或纤维素样坏死提示TA-AAV。
  • 疑似GCA合并非典型特征或颞动脉异常时应检测ANCA。

核心结论

  • 以颞动脉炎表现揭示的AAV应被考虑用于GCA的非典型表现、对糖皮质激素治疗抵抗或早期复发的诊断。
  • 颞动脉活检标本检测小分支血管炎和/或纤维素样坏死可能有用。
  • 疑似GCA合并非典型临床特征和/或颞动脉活检异常时应检测ANCA。

研究设计与样本

  • 采用Log-rank检验,以风险比(HR)和95%置信区间(95%CI)评估治疗失败风险。

主要发现

  • 33例(66%)TA-AAV患者出现GCA非典型症状:耳鼻喉受累32%,肾脏、肺和神经系统受累分别为26%、20%和16%。
  • 33例患者在疾病起病时筛查ANCA,88%结果阳性,其中20例诊断为早期TA-AAV;30例患者AAV诊断延迟中位间隔15个月。
  • 与GCA对照相比,TA-AAV患者更年轻(中位年龄70岁 vs 74岁)、男性更多(48% vs 30%)、非典型表现频率高且C反应蛋白水平更高(中位10.8 mg/dl vs 7.0 mg/dl)。
  • TA-AAV患者颞动脉活检显示纤维素样坏死和小分支血管炎各占23%,而GCA对照均无此表现。
  • 早期TA-AAV与GCA对照的无治疗失败生存相当,而延迟TA-AAV患者治疗失败风险显著高于对照(HR 3.85,95%CI 1.97-7.51;P < 0.0001)。

关键数值与推荐

  • TA-AAV患者中位年龄70岁,66%有GCA非典型症状,耳鼻喉受累32%,肾脏、肺和神经系统受累分别为26%、20%和16%。
  • 33例起病时筛查ANCA者88%阳性;30例AAV诊断延迟中位15个月。
  • TA-AAV vs GCA对照:中位年龄70岁 vs 74岁,男性48% vs 30%,C反应蛋白中位10.8 mg/dl vs 7.0 mg/dl。
  • 颞动脉活检:TA-AAV患者纤维素样坏死和小分支血管炎各23%,GCA对照均无。
  • 延迟TA-AAV vs GCA对照治疗失败风险:HR 3.85,95%CI 1.97-7.51;P < 0.0001。

临床怎么用

  • 对疑似GCA合并非典型临床表现(如耳鼻喉、肾脏、肺或神经系统受累)或颞动脉活检异常者应检测ANCA。
  • 颞动脉活检标本应评估小分支血管炎和纤维素样坏死以提示TA-AAV。
  • 对糖皮质激素治疗抵抗或早期复发的GCA患者应考虑TA-AAV诊断,避免误诊和不当治疗。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Temporal arteritis (TA) is a typical manifestation of giant cell arteritis (GCA). Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are rarely revealed by TA manifestations, leading to a risk of misdiagnosis of GCA and inappropriate treatments. This study was undertaken to describe the clinical, biologic, and histologic presentations and outcomes in cases of TA revealing AAV (TA-AAV) compared to controls with classic GCA. METHODS: In this retrospective case-control study, the characteristics of patients with TA-AAV were compared to those of control subjects with classic GCA. Log-rank test, with hazard ratios (HRs) and 95% confidence intervals (95% CIs), was used to assess the risk of treatment failure. RESULTS: Fifty patients with TA-AAV (median age 70 years) were included. Thirty-three patients (66%) presented with atypical symptoms of GCA (ear, nose, and throat involvement in 32% of patients, and renal, pulmonary, and neurologic involvement in 26%, 20%, and 16% of patients, respectively). Blood samples were screened for ANCAs at the time of disease onset in 33 patients, and results were positive in 88%, leading to a diagnosis of early TA-AAV in 20 patients. The diagnosis of AAV was delayed a median interval of 15 months in 30 patients. Compared to controls with GCA, patients with TA-AAV were younger (median age 70 years versus 74 years), were more frequently men (48% versus 30%), and had high frequencies of atypical manifestations and higher C-reactive protein levels (median 10.8 mg/dl versus 7.0 mg/dl). In patients with TA-AAV, temporal artery biopsy (TAB) showed fibrinoid necrosis and small branch vasculitis in 23% of patients each, whereas neither of these characteristics was evident in controls with GCA. Treatment failure-free survival was comparable between early TA-AAV cases and GCA controls, whereas those with delayed TA-AAV had a significantly higher risk of treatment failure compared to controls (HR 3.85, 95% CI 1.97-7.51; P < 0.0001). CONCLUSION: TA-AAV should be considered diagnostically in cases of atypical manifestations of GCA, refractoriness to glucocorticoid treatment, or early relapse. Analysis of TAB specimens for the detection of small branch vasculitis and/or fibrinoid necrosis could be useful. Detection of ANCAs should be performed in cases of suspected GCA with atypical clinical features and/or evidence of temporal artery abnormalities on TAB.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Delaval L, Samson M, Schein F, et al. Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study. Arthritis Rheumatol. 2020. PMID: 32951354. doi:10.1002/art.41527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。